Artiva Biotherapeutics, Inc.

US$4.15As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:ARTVHealthcare
Country USA
PE (Fwd) •••
TSR 2Y CAGR (36.86%)
Div yield —
ROE (36.58%)
Biotechnology
Beta (5Y) 2.68
PE TTM —
TSR TTM (0.48%)
Mkt cap US$202.9M
ROIC (23.13%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$4.12
(0.84%)
(71.85%)
Buy 6|0|11|9|3
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.07
0.07
0.07
0.07
27.66%
21.68%
15.29%
16.69%
Revenue$M
18.12
18.89
19.17
19.63
4.79%
5.65%
9.80%
12.24%
Peers (US$202.9M)
Cap (US$)
PE
202.5M
—
203.6M
—
Capital
TTM
5Y
10Y
Leveragex
0.924
(0.021)
(0.024)
EBIT/Intx
2.589
0.538
0.535
Own earn%
39.42
3.06
7.19
Sh yield%
9.66
10.93
8.10
Owners
Insiders/Inst%
3.48
63.96
Short interest%
5.11
SBC / revenue%
1.06
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
1
Op margin range%
0–7
$1 testx
−0.8
Incr. ROIC%
4